In a preliminary retrospective analysis, estrogen-receptor expression was a marker of a benefit of tamoxifen in patients with ductal carcinoma in situ. 77 Tamoxifen reduced the risk of recurrence ...

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

Individualized Local Recurrence Estimates for Ductal Carcinoma In Situ Laura E.G. Warren , Jennifer R. Bellon Journal of Clinical Oncology 2024 42: 27 , 3167-3169 View Options ...

Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, accounts for 1 of every 5 new breast cancer diagnoses. It's an uncontrolled growth of cells within the breast ducts.

Babytam is the 5-mg daily dose of tamoxifen being studied in the ongoing TAM-01 study, which is investigating incidence of invasive breast cancer or ductal carcinoma in situ among high-risk women ...

DelveInsight's "Ductal Carcinoma in Situ Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ductal Carcinoma in Situ, historical and ...

Ductal carcinoma in situ (DCIS) is a heterogeneous entity that has continued to perplex clinicians and patients despite extensive efforts to characterize its behavior and best treatment strategies. As ...

Dr. Beryl McCormick answers the question: 'How do you treat DCIS?' — -- Question: What are the treatment recommendations for ductal carcinoma in situ? Answer: The two major treatment ...

Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ.

The prognosis for ductal carcinoma in situ is excellent. Regardless of what local treatment options patients may choose, their survival from this kind of breast cancer is in the range of about 99 ...

Doctors often call this type of breast cancer ductal carcinoma in situ (DCIS). It gets this name because the cancer is only in the breast ducts that carry milk . Sometimes you may also hear it ...